Kimberly M. Murphy

Director, ORAGENICS INC.

Companies

ORAGENICS INCBoard member May 4, 2020 to Sep 20, 2024¹
ORAGENICS INCChief executive officer Jun 24, 2022 to Aug 10, 2023²
ORAGENICS INCPresident Jun 24, 2022 to Aug 10, 2023²
Clarus Therapeutics (United States)Board member Dec 17, 2020 to Jun 9, 2022³
Onconetix, Inc.Board member Feb 17, 2022 to May 27, 2022⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ORAGENICS INC OGEN25,000 shares⁵$11.0K at $0.44Aug 8, 2023
Clarus Therapeutics (United States)5,766 shares⁶Jun 7, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 8, 2023Granted 25,000 shares of ORAGENICS INC⁵
Jun 7, 2022Granted 1,922 shares of Clarus Therapeutics (United States)⁶
Dec 12, 2021Granted 3,844 shares of Clarus Therapeutics (United States)⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARORAGENICS INC, Board member
2
SEC EDGARORAGENICS INC, Chief executive officer
3
SEC EDGARClarus Therapeutics (United States), Board member
4
SEC EDGAROnconetix, Inc., Board member
5
SEC EDGARORAGENICS INC shares after the filing of Aug 8, 2023
6
SEC EDGARClarus Therapeutics (United States) shares after the filing of Jun 7, 2022
7
SEC EDGARForm 4 filed Dec 14, 2021